Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Generic
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AGN | Allergan plc | -2.08% | 184.30 | 2.8% | $293.03m | |
| TEVA | Teva Pharmaceutical Industries Limited Sponsored ADR | -0.60% | 23.27 | 2.1% | $266.77m | |
| ZTS | Zoetis, Inc. Class A | 0.00% | 89.28 | 1.9% | $151.16m | |
| MYL | Mylan N.V. | -0.72% | 37.21 | 3.2% | $95.73m | |
| TXMD | TherapeuticsMD, Inc. | -2.23% | 6.14 | 27.8% | $13.06m | |
| RDY | Dr. Reddy's Laboratories Ltd. Sponsored ADR | -1.05% | 35.69 | 2.0% | $8.74m | |
| ABEO | Abeona Therapeutics, Inc. | -2.44% | 14.00 | 7.9% | $5.94m | |
| KIN | Kindred Biosciences, Inc. | -1.84% | 13.35 | 0.3% | $2.28m | |
| LFVN | LifeVantage Corporation | -3.26% | 12.48 | 3.3% | $2.25m | |
| JAGX | Jaguar Animal Health, Inc. | 1.46% | 0.55 | 0.7% | $0.06m | |
| CPHI | China Pharma Holdings, Inc. | -5.54% | 0.21 | 0.1% | $0.03m |
Company Profile
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Dallas, TX.